Alder BioPharmaceuticals

$18.64
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$8.44 (83.90%) Today
+$0.14 (0.76%) As of 6:57 PM EDT after-hours

Why Robinhood?

You can buy or sell ALDR and other stocks, options, ETFs, and crypto commission-free!

About ALDR

Alder BioPharmaceuticals, Inc. Common Stock, also called Alder BioPharmaceuticals, is a clinical-stage biopharmaceutical company, which discovers, develops and commercializes various therapeutic antibodies. Read More Its product portfolio includes ALD1910, a preclinical product candidate also in development as a migraine prevention therapy. ALD1910 is a monoclonal antibody that inhibits pituitary adenylate cyclase-activating polypeptide-38 (PACAP-38), another protein that is active in mediating the initiation of migraine; and Clazakizumab, Alder's third program, is a monoclonal antibody candidate that inhibits interleukin-6. The company was founded by Randall C. Schatzman, Mark J. Litton, and John A. Latham in January 2004 and is headquartered in Bothell, WA.

Employees
202
Headquarters
Bothell, Washington
Founded
2004
Market Cap
841.39M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
718.13K
High Today
$18.87
Low Today
$18.34
Open Price
$18.48
Volume
49.58M
52 Week High
$18.87
52 Week Low
$8.39

Collections

ALDR News

MarketWatch12h

Alder BioPharmaceuticals stock rockets on heavy volume after $1.95 billion buyout deal

9,221
Benzinga12h

Alder Alert: Johnson Fistel Investigates Proposed Sale of Alder BioPharmaceuticals, Inc.; Are Shareholders Getting a Fair Deal?

452
Reuters18h

Lundbeck to buy migraine treatment developer Alder BioPharmaceuticals

242

ALDR Earnings

-$1.73
-$1.39
-$1.06
-$0.72
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Expected Nov 4, After Hours
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.